Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Vaginal Atrophy in Breast Cancer Patients
Interventions: DRUG: Placebo|DRUG: Prasterone (DHEA)
Sponsor: EndoCeutics Inc.
Collaborators: AMAG Pharmaceuticals, Inc.